Company / FCF Margin
Veracyte, Inc. FCF Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
24.5%
FY2025
5-year range
-16.9% / 24.5%
FY2021-FY2025
Trend
+71.1%
vs FY2024
Sector context
#9 of 139
Health Care
What the data says
Among 139 Health Care companies, Veracyte, Inc. is in the top 6% for fcf margin. FCF Margin has increased for 4 consecutive years, from -16.9% in FY2021 to 24.5% in FY2025.
Based on SEC 10-K filings.
24.5% in FY2025 with a 5-year CAGR of +35.2%. Top quartile in the Health Care sector.
Improved from 9.5% to 24.5% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- +24.8pp
- 5-Year Change
- +35.2pp
- 10-Year Change
- -
Sector benchmark
Top 6% in Health CareTop 6% of 139This company 24.5% Sector average -217.0%
▼
+111.3% above sector average
Key checks
Key Insights
- Veracyte, Inc.'s fcf margin has grown for 4 consecutive years.
- In FY2025, fcf margin increased 71.1% year-over-year.
- Currently 241.5pp above the Health Care sector average.
- Lowest fcf margin in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 6.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 24.5% | +71.1% |
| FY2024 | 14.3% | +50.8% |
| FY2023 | 9.5% | +2891.2% |
| FY2022 | -0.3% | +98.0% |
| FY2021 | -16.9% | -57.8% |
| FY2020 | -10.7% | -114.9% |
| FY2019 | -5.0% | +70.3% |
| FY2018 | -16.7% | +53.1% |
| FY2017 | -35.7% | +27.9% |
| FY2016 | -49.5% | +26.1% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026